Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Long-term follow up of patients with mesothelioma treated with dendritic cell therapy in three phase I trials.
- Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.
- Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma